When evaluating the presence of breast tumors that overexpress HER2 and triple negatives to verify whether these histological subtypes are present or not, a higher number of triple-negative and HER2-positive tumors was found in patients with obesity, but there was no statistically significant difference. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.